After 3 Years, IBM's Watson Disappoints In Cancer Care05:43
Download

Play
The logo of IBM is seen at their booth prior to the opening of the CeBIT IT fair on March 5, 2012 in Hanover, central Germany. (Odd Andersen/AFP/Getty Images)
The logo of IBM is seen at their booth prior to the opening of the CeBIT IT fair on March 5, 2012 in Hanover, central Germany. (Odd Andersen/AFP/Getty Images)
This article is more than 2 years old.

Three years ago, IBM began selling its cloud-based supercomputer Watson to hospitals as a revolutionary tool in diagnosing and treating cancer. But according to an investigation by STAT, many hospitals and doctors say Watson has had trouble learning about different types of cancer, let alone suggesting the best course of treatment.

Here & Now's Robin Young talks with STAT's Ike Swetlitz (@ikeswetlitz) about the findings.

This segment aired on September 6, 2017.

Related:

Support the news

+Join the discussion
TwitterfacebookEmail

Support the news